AstraZeneca has selected a candidate to progress in the type 1 diabetes (T1D) Treg cell therapy programme, as per an 18 November press release. It is the first asset licensed by the British big ...

Although targeting Tregs to restore anti-tumor immunity is an emerging area in cancer therapy, systemically inhibiting Tregs ...

In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ... meet any of these criteria are not eligible for ...

Immune cells called regulatory T cells have long been known for their role in countering inflammation. In the setting of ...

an area of therapeutics development that is viewed as being at the forefront of extending the role of cell therapy beyond cancer. As their name suggests, Treg cells play a key role in controlling ...

You will be redirected to our submission process. Treg cell therapy holds immense potential to revolutionize the treatment of inflammatory and autoimmune diseases by restoring immunological balance.

We review the function of regulatory T cells and the pathways by which they exert immune tolerance in the intestinal mucosa. We explore the principles and challenges of manufacturing a cell therapy, ...